sublingual delivery glp-1 receptor agonists Schematic illustration of monoagonists, dual and triple GLP-1 receptor agonists for individualized
Description
Flexible dose adjustment of oral semaglutide led to superior glycemic control and weight loss at week 52 versus sitagliptin and was well tolerated
Complementary GLP-1RA and dietary supplement interventions could benefit the patient and help prevent unintended consequences of GLP-1RA treatment
Clin Med Insights Endocrinol Diabetes
Theres also a noted risk for thyroid cancer
PKA induction from native GLP-1 phosphorylates a key serine residue in NOS [40]
There was no weight gain and a very low risk of hypoglycemia
